Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Peripheral washout sign on contrast-enhanced MR images of the breast.

Sherif H, Mahfouz AE, Oellinger H, Hadijuana J, Blohmer JU, Taupitz M, Felix R, Hamm B.

Radiology. 1997 Oct;205(1):209-13.

PMID:
9314987
2.
3.

MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.

Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Erning LJ, Hendriks JH, Holland R, Ruys SH.

Radiology. 1994 Dec;193(3):777-81.

PMID:
7972823
4.
5.

Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.

Mussurakis S, Buckley DL, Drew PJ, Fox JN, Carleton PJ, Turnbull LW, Horsman A.

Clin Radiol. 1997 Jul;52(7):516-26.

PMID:
9240704
6.

Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.

Quillin SP, Atilla S, Brown JJ, Borrello JA, Yu CY, Pilgram TK.

Magn Reson Imaging. 1997;15(3):275-85.

PMID:
9201674
7.

Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.

Gribbestad IS, Nilsen G, Fjøsne HE, Kvinnsland S, Haugen OA, Rinck PA.

J Magn Reson Imaging. 1994 May-Jun;4(3):477-80.

PMID:
8061451
8.

Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.

Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, Ohno S.

Radiology. 1996 Sep;200(3):639-49.

PMID:
8756909
9.

Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.

Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, Londy F, Shapiro B, Gross MD, Thompson NW.

Radiology. 1995 Nov;197(2):411-8.

PMID:
7480685
10.

Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.

Kuhl CK, Bieling H, Gieseke J, Ebel T, Mielcarek P, Far F, Folkers P, Elevelt A, Schild HH.

Radiology. 1997 Jan;202(1):87-95.

PMID:
8988196
11.

Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.

Nunes LW, Schnall MD, Siegelman ES, Langlotz CP, Orel SG, Sullivan D, Muenz LA, Reynolds CA, Torosian MH.

AJR Am J Roentgenol. 1997 Aug;169(2):409-15.

PMID:
9242744
12.

Breast disease: tissue characterization with Gd-DTPA enhancement profiles.

Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT.

Radiology. 1990 Feb;174(2):491-4.

PMID:
2296657
14.

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.

J Magn Reson Imaging. 2008 Nov;28(5):1157-65. doi: 10.1002/jmri.21570.

PMID:
18972357
15.

Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?

Hamm B, Mahfouz AE, Taupitz M, Mitchell DG, Nelson R, Halpern E, Speidel A, Wolf KJ, Saini S.

Radiology. 1997 Mar;202(3):677-82.

PMID:
9051015
16.

[MR imaging for breast cancer].

Seki T, Hachiya J, Nitatori T, Yokoyama K, Fukushima H, Uchigasaki S.

Nihon Geka Gakkai Zasshi. 1996 May;97(5):347-56. Japanese.

PMID:
8709936
17.

Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.

Choi N, Han BK, Choe YH, Kim HS.

J Comput Assist Tomogr. 2005 Nov-Dec;29(6):834-41.

PMID:
16272861
18.

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R.

Radiology. 1996 Jul;200(1):59-67.

PMID:
8657946
19.

Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.

Hamm B, Thoeni RF, Gould RG, Bernardino ME, Lüning M, Saini S, Mahfouz AE, Taupitz M, Wolf KJ.

Radiology. 1994 Feb;190(2):417-23.

PMID:
8284392
20.

Laser therapy for breast cancer: MR imaging and histopathologic correlation.

Mumtaz H, Hall-Craggs MA, Wotherspoon A, Paley M, Buonaccorsi G, Amin Z, Wilkinson I, Kissin MW, Davidson TI, Taylor I, Bown SG.

Radiology. 1996 Sep;200(3):651-8.

PMID:
8756910

Supplemental Content

Support Center